{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:48:35Z","timestamp":1791679715994,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"SM Sohail Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04822-1","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:34:34Z","timestamp":1791668074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of miRNA-500 and AGE-RAGE axis in the development of thyroid cancer"],"prefix":"10.1007","volume":"91","author":[{"given":"Nazia","family":"Shoaib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5560-5053","authenticated-orcid":false,"given":"Rizwana Sanaullah","family":"Waraich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hurtamina","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Zauraiz","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Sumayya","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadieleh Adnan","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"issue":"1","key":"4822_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13044-026-00288-5","volume":"19","author":"L Wang","year":"2026","unstructured":"L. Wang, R. Li, X. Zeng, H. Zhang, Evaluation and projection of the global burden of thyroid cancer from 1990 to 2035: an analysis based on the Global Burden of Disease Study. Thyroid Res. 19(1), 10 (2026)","journal-title":"Thyroid Res."},{"key":"4822_CR2","doi-asserted-by":"publisher","first-page":"109995","DOI":"10.1016\/j.cellsig.2021.109995","volume":"83","author":"M Budakoti","year":"2021","unstructured":"M. Budakoti, A.S. Panwar, D. Molpa, R.K. Singh, D. B\u00fcsselberg, A.P. Mishra et al., Micro-RNA: The darkhorse of cancer. Cell. Signal. 83, 109995 (2021)","journal-title":"Cell. Signal."},{"key":"4822_CR3","doi-asserted-by":"crossref","unstructured":"Z. Zhang, R. Cui, H. Li, J. Li, miR-500 promotes cell proliferation by directly targetting LRP1B in prostate cancer. Biosci. Rep. 2019;39(4)","DOI":"10.1042\/BSR20181854"},{"key":"4822_CR4","doi-asserted-by":"crossref","unstructured":"M. Jiang, L.Y. Zhou, N. Xu, Q. An. Down-regulation of miR-500 and miR-628 suppress non-small cell lung cancer proliferation, migration and invasion by targeting ING1., Biomedicine, & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie. 2018;108:1628-39","DOI":"10.1016\/j.biopha.2018.09.145"},{"issue":"3","key":"4822_CR5","first-page":"1799","volume":"19","author":"Y Li","year":"2020","unstructured":"Y. Li, Z. Chen, The oncogenic role of microRNA-500a in colorectal cancer. Oncol. Lett. 19(3), 1799\u20131805 (2020)","journal-title":"Oncol. Lett."},{"issue":"5","key":"4822_CR6","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1159\/000491472","volume":"47","author":"L Bao","year":"2018","unstructured":"L. Bao, M. Zhang, S. Han, Y. Zhan, W. Guo, F. Teng et al., MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology. 2018;47(5):2046\u20132055","journal-title":"Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"key":"4822_CR7","doi-asserted-by":"crossref","unstructured":"M.B. Nelappana, P. Wityk, C.C. Applegate, G. Okoro, L. Kalinowski, I.T. Dobrucki et al., The Role of the Receptor for Advanced Glycation End-Products in Cancer: Evidence from a Systematic Review and Meta-Analysis. bioRxiv: the preprint server for biology. 2026","DOI":"10.64898\/2026.02.13.705839"},{"issue":"20","key":"4822_CR8","doi-asserted-by":"publisher","first-page":"9983","DOI":"10.3390\/ijms26209983","volume":"26","author":"YS Khan","year":"2025","unstructured":"Y.S. Khan, A. Farhana, M. Kuddus, S.M.A. Shahid, A. Alsrhani, A.A. Osman et al., MicroRNA-125b-5p Drives MMP-2 Expression via Activation of RAGE-38MAPK-p65\/p50NF-\u03baB Axis: A Novel Mechanism in Human Lung Cancer Cells. Int. J. Mol. Sci. 26(20), 9983 (2025)","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"4822_CR9","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.4081\/ejh.2025.4238","volume":"69","author":"H Wang","year":"2025","unstructured":"H. Wang, D. Sidike, P. Liu, L. Suo, H. Niyazi, miR-129-5p regulates HMGB1\/RAGE axis to inhibit pyroptosis and ameliorate cervical epithelial cell deterioration. Eur. J. histochemistry: EJH. 69(4), 4238 (2025)","journal-title":"Eur. J. histochemistry: EJH"},{"issue":"3","key":"4822_CR10","first-page":"2621","volume":"18","author":"C Yin","year":"2018","unstructured":"C. Yin, G. Zhang, R. Sun, X. Pan, X. Wang, H. Li et al., miR-185-5p inhibits F-actin polymerization and reverses epithelial mesenchymal transition of human breast cancer cells by modulating RAGE. Mol. Med. Rep. 18(3), 2621\u20132630 (2018)","journal-title":"Mol. Med. Rep."},{"key":"4822_CR11","doi-asserted-by":"publisher","first-page":"175861","DOI":"10.1016\/j.ejphar.2023.175861","volume":"954","author":"X Dai","year":"2023","unstructured":"X. Dai, Y. Hou, T. Deng, G. Lin, Y. Cao, G. Yu et al., A specific RAGE-binding peptide inhibits triple negative breast cancer growth through blocking of Erk1\/2\/NF-\u03baB pathway. Eur. J. Pharmacol. 954, 175861 (2023)","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"4822_CR12","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1089\/thy.2014.0257","volume":"25","author":"MR Medapati","year":"2015","unstructured":"M.R. Medapati, M. Dahlmann, S. Ghavami, K.A. Pathak, L. Lucman, T. Klonisch et al., RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells. Thyroid: official J. Am. Thyroid Association. 25(5), 514\u2013527 (2015)","journal-title":"Thyroid: official J. Am. Thyroid Association"},{"issue":"D1","key":"4822_CR13","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"D. Szklarczyk, A.L. Gable, D. Lyon, A. Junge, S. Wyder, J. Huerta-Cepas et al., STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47(D1), D607\u2013D13 (2019)","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"4822_CR14","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"P. Shannon, A. Markiel, O. Ozier, N.S. Baliga, J.T. Wang, D. Ramage et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13(11), 2498\u20132504 (2003)","journal-title":"Genome Res."},{"issue":"10","key":"4822_CR15","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/pros.23361","volume":"77","author":"B Cai","year":"2017","unstructured":"B. Cai, W. Chen, Y. Pan, H. Chen, Y. Zhang, Z. Weng et al., Inhibition of microRNA-500 has anti-cancer effect through its conditional downstream target of TFPI in human prostate cancer. Prostate. 77(10), 1057\u20131065 (2017)","journal-title":"Prostate"},{"issue":"6","key":"4822_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/cells8060547","volume":"8","author":"C Antognelli","year":"2019","unstructured":"C. Antognelli, S. Moretti, R. Frosini, E. Puxeddu, A. Sidoni, V.N. Talesa, Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer. Cells. 8(6), 547 (2019)","journal-title":"Cells"},{"issue":"1","key":"4822_CR17","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1038\/s41598-026-43471-2","volume":"16","author":"H Tan","year":"2026","unstructured":"H. Tan, L. Liu, Y. Yi, C. Valenzuela, Q. Zhao, Z. Zhang et al., Circulating levels of high mobility group box-1 and nucleophosmin\/B23 proteins and clinical significance in debut non-small cell lung cancer patients. Sci. Rep. 16(1), 12481 (2026)","journal-title":"Sci. Rep."},{"issue":"1","key":"4822_CR18","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41419-026-08649-6","volume":"17","author":"W Song","year":"2026","unstructured":"W. Song, Z. Liu, C. Shi, G. Wang, L. He, Z. Chen et al., RAN-S100A10-EGFR axis facilitates papillary thyroid cancer metastasis by PI3K\/AKT signaling. Cell. Death Dis. 17(1), 510 (2026)","journal-title":"Cell. Death Dis."},{"key":"4822_CR19","doi-asserted-by":"publisher","first-page":"512027","DOI":"10.1155\/2015\/512027","volume":"2015","author":"S Mardente","year":"2015","unstructured":"S. Mardente, E. Mari, I. Massimi, F. Fico, A. Faggioni, F. Pulcinelli et al., HMGB1-Induced Cross Talk between PTEN and miRs 221\/222 in Thyroid Cancer. Biomed. Res. Int. 2015, 512027 (2015)","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"4822_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1210\/endrev\/bnad005","volume":"44","author":"V Vella","year":"2023","unstructured":"V. Vella, R. Lappano, E. Bonavita, M. Maggiolini, R.B. Clarke, A. Belfiore et al., Insulin\/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy. Endocr. Rev. 44(4), 693\u2013723 (2023)","journal-title":"Endocr. Rev."},{"key":"4822_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","volume":"28","author":"GP Sims","year":"2010","unstructured":"G.P. Sims, D.C. Rowe, S.T. Rietdijk, R. Herbst, A.J. Coyle, HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 28, 367\u2013388 (2010)","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"4822_CR22","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.3892\/or.2012.2058","volume":"28","author":"S Mardente","year":"2012","unstructured":"S. Mardente, E. Mari, F. Consorti, Di C. Gioia, R. Negri, M. Etna et al., HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells. Oncol. Rep. 28(6), 2285\u20132289 (2012)","journal-title":"Oncol. Rep."},{"key":"4822_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fimmu.2019.00104","volume":"10","author":"B Dhillon","year":"2019","unstructured":"B. Dhillon, F. Aleithan, Z. Abdul-Sater, A.A. Abdul-Sater, The Evolving Role of TRAFs in Mediating Inflammatory Responses. Front. Immunol. 10, 104 (2019)","journal-title":"Front. Immunol."},{"issue":"1","key":"4822_CR24","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/ar4483","volume":"16","author":"S Ito","year":"2014","unstructured":"S. Ito, Y. Hara, T. Kubota, CARD8 is a negative regulator for NLRP3 inflammasome, but mutant NLRP3 in cryopyrin-associated periodic syndromes escapes the restriction. Arthritis Res. Ther. 16(1), R52 (2014)","journal-title":"Arthritis Res. Ther."},{"key":"4822_CR25","doi-asserted-by":"publisher","first-page":"1479505","DOI":"10.3389\/fimmu.2024.1479505","volume":"15","author":"X Zhang","year":"2024","unstructured":"X. Zhang, B. Li, T. Lan, C. Chiari, X. Ye, K. Wang et al., The role of interleukin-17 in inflammation-related cancers. Front. Immunol. 15, 1479505 (2024)","journal-title":"Front. Immunol."},{"issue":"3","key":"4822_CR26","doi-asserted-by":"publisher","first-page":"e33379","DOI":"10.1371\/journal.pone.0033379","volume":"7","author":"QL Li","year":"2012","unstructured":"Q.L. Li, F.M. Gu, Z. Wang, J.H. Jiang, L.Q. Yao, C.J. Tan et al., Activation of PI3K\/AKT and MAPK pathway through a PDGFRbeta-dependent feedback loop is involved in rapamycin resistance in hepatocellular carcinoma. PLoS One. 7(3), e33379 (2012)","journal-title":"PLoS One"},{"key":"4822_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3389\/fendo.2018.00471","volume":"9","author":"C Giuliani","year":"2018","unstructured":"C. Giuliani, I. Bucci, G. Napolitano, The Role of the Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and Cancer. Front. Endocrinol. (Lausanne). 9, 471 (2018)","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2\u20133","key":"4822_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0167-4889(00)00087-2","volume":"1498","author":"AM Schmidt","year":"2000","unstructured":"A.M. Schmidt, S.D. Yan, S.F. Yan, D.M. Stern, The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta. 1498(2\u20133), 99\u2013111 (2000)","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"4822_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.14740\/jocmr2480w","volume":"8","author":"S Jin","year":"2016","unstructured":"S. Jin, O. Borkhuu, W. Bao, Y.T. Yang, Signaling Pathways in Thyroid Cancer and Their Therapeutic Implications. J. Clin. Med. Res. 8(4), 284\u2013296 (2016)","journal-title":"J. Clin. Med. Res."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04822-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04822-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04822-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:02:37Z","timestamp":1791676957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04822-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4822"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04822-1","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]},"assertion":[{"value":"29 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Ethics Review Committee. Written informed consent was obtained from all participants prior to enrollment.","order":1,"name":"Ethics","label":"Human Ethics and Consent to Participate declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"341"}}